Gannon Steven

Director at XENE

Sold, on record
$1.2M
Dollars the filings state
Form 4 sales
3
Latest Aug 11, 2026
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • XENEXenon Pharmaceuticals Inc.Director

Sales by reason

0
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice XENENotice
    Mar 7 2024

    Filed to sell 13,000 shares ($600k)

    Gannon Steven, Director

    No 10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale XENEUnusual
    Mar 7 same day

    Sold 13,000 shares at $46.28 ($602k)

    Gannon Steven, Director

    No 10b5-1 planSold 86.7% of holdings ($694k position)2,000 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 4 sale XENENo plan
    Jun 5 +455 days

    Sold 3 shares at $30.48 ($91)

    Gannon Steven, Director

    No 10b5-1 planSold 0% of holdings ($218k position)7,141 shares leftFiling

  4. 4 Form 4 sale XENEUnusual
    Aug 11 +432 days

    Sold 10,000 shares at $64.06 ($641k)

    Gannon Steven, Director

    No 10b5-1 planSold 84.2% of holdings ($760k position)1,870 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Gannon Steven
Source
Aug 11, 2026XENEDirectorForm 4 sale10,000$641k84.2%UnusualSEC
Jun 5, 2025XENEDirectorForm 4 sale3$910.0%No planSEC
Mar 7, 2024XENEDirectorForm 4 sale13,000$602k86.7%UnusualSEC
Mar 7, 2024XENEDirectorForm 144 notice13,000$600kNoticeSEC